Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Regulatory T cell (Treg) pathway is a crucial mechanism for maintaining immune homeostasis and self-tolerance. It involves a specialized subset of CD4+ T cells characterized by the expression of FOXP3 and high levels of CD25. Tregs suppress excessive or inappropriate immune responses, preventing autoimmunity and controlling inflammation. They utilize multiple mechanisms, including cytokine secretion, cytokine deprivation, and inhibitory receptor signaling. Modulation of this pathway holds therapeutic potential in autoimmune diseases, cancer immunotherapy, and transplantation tolerance.
Multiple mechanisms including: cytokine secretion (IL-10, IL-35), cytokine deprivation (IL-2), inhibitory receptor signaling (CTLA-4, PD-1), adenosine production (CD39/CD73)
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Regulatory T Cell Pathway (Treg Pathway).